BFLY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Butterfly Network Inc (BFLY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, positive analyst sentiment, and recent price momentum make it an attractive opportunity. Despite some overbought technical indicators, the long-term growth prospects outweigh short-term risks.
The MACD is positive and expanding, indicating bullish momentum. The RSI is at 88.896, which signals overbought conditions, suggesting the stock may be overextended in the short term. Moving averages are converging, and the stock is trading near its resistance level of R2: 4.979. The recent price surge of 50.65% in regular market hours and 1.28% in post-market reflects strong upward momentum.
Q4 2025 revenue increased by 41% YoY to $31.5 million, exceeding expectations.
Analysts have raised price targets and maintained Buy ratings, citing strong revenue growth and business expansion.
Projected FY 2026 revenue growth between $117 million and $121 million.
Gross margin improved to 67.34%, up 9.59% YoY.
Positive news sentiment and strong pre-market and regular market price performance.
RSI indicates overbought conditions, suggesting potential short-term pullback.
Net income remains negative at -$15.3 million, though losses have narrowed.
EPS dropped by 25% YoY, reflecting ongoing profitability challenges.
In Q4 2025, revenue grew by 41% YoY to $31.5 million, driven by core business and partnerships. Net income narrowed to -$15.3 million, reflecting a 15.52% YoY improvement. Gross margin increased to 67.34%, up 9.59% YoY, showcasing operational efficiency. However, EPS dropped to -0.06, down 25% YoY, indicating profitability challenges.
Analysts have raised price targets and maintained Buy ratings. Craig-Hallum increased the price target to $5.25 from $3.25, citing strong revenue growth and business expansion. Lake Street raised the price target to $5.50 from $4, highlighting the platform's payoff and multiple expansion potential. Freedom Capital initiated coverage with a Buy rating and a $5 price target, emphasizing growth in the core ultrasound business.
